Zimmer Strengthened by Addition of Innovative Instrumentation Systems and Advanced Surgical Cutting Technology
WARSAW, Ind., Jan. 12, 2012 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today that it has acquired Reno, Nevada-based Synvasive Technology, Inc. The acquisition will enhance Zimmer’s product portfolio through the addition of Synvasive’s STABLECUT® surgical saw blades, as well as the eLIBRA® Dynamic Knee Balancing System™ for soft tissue balancing.
“Zimmer is committed to developing the industry’s most innovative range of technologies to support personalized therapies, from improved surgical power equipment to patient specific instrumentation and other intelligent tools that support optimal surgical outcomes,” said Jeff McCaulley, President, Zimmer Reconstructive. “The acquisition of Synvasive Technology further strengthens our surgical resection and advanced instrumentation offerings.”
In the surgical resection market, Synvasive has long been recognized as a leader in surgical cutting tools with its STABLECUT® blades. Synvasive’s eLIBRA® Dynamic Knee Balancing System™ is the premiere soft-tissue balancing solution in the industry. This offering provides patient specific soft-tissue balancing during knee replacement surgery, establishing the optimal position of the femoral implant to enable a less-invasive surgical approach as well as excellent stability, range of motion and patella tracking.
About Zimmer
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2010 sales were approximately $4.2 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.
About Synvasive Technology
Located in Reno, Nevada, Synvasive Technology, Inc. develops, manufactures and distributes patented and proprietary instruments enhancing reconstructive orthopaedic surgery. For nearly twenty years, Synvasive has been a provider of some of the most advanced surgical cutting technology in the market. Synvasive is the exclusive provider of the patented large bone surgical saw blades, STABLECUT®, an industry gold standard.
Website Information
We routinely post important information for investors on our website, www.zimmer.com, in the “Investor Relations” section. We intend to use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management’s beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and “seeks” or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
